Nasol, Baby Boy .
HRN: 23-43-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
AMPICILLIN 250MG (VIAL)
07/31/2023
08/07/2023
IVTT
115mg
Q12
PSNB
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes